Microdroplet-enhanced chip platform for high-throughput immunotherapy marker screening from extracellular vesicle RNAs and membrane proteins
Biosensors and Bioelectronics · 2025
DOI: 10.1016/j.bios.2024.116748 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025. Verfasst von Chuanhao Tang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetic Engineering, Beijing Institute of Biotechnology, Beijing, 100071, China; Department of Medical Oncology, Peking University Inte…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Biosensing Techniques, Immunotherapy, Membrane Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Extracellular vesicles (EVs) are considered as promising candidates for predicting patients who respond to immunotherapy. Nevertheless, simultaneous detection of multiple EVs markers still presents significant technical challenges. In this work, we developed a high-throughput microdroplet-enhanced chip (MEC) platform, which utilizes thousands of individual microchambers (∼pL) as reactors, accelerating the detection efficiency of the CRISPR/Cas systems and increasing the sensitivity by up to 100-fold (aM level). Ten biomarkers (including 5 RNAs and 5 proteins) from patients' EVs are successfully detected on one chip, and the comprehensive markers show increased accuracy (AUC 0.911) than the individual marker for the efficacy prediction of immunotherapy. This platform provides a high-throughput yet sensitive strategy for screening immunotherapy markers in clinical.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetic Engineering, Beijing Institute of Biotechnology, Beijing, 100071, China; Department of Medical Oncology, Peking University International Hospital, Beijing, 102206, China.
- School of Engineering Medicine, Beihang University, Beijing, 100191, China; Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical Engineering, Beihang University, Beijin…
- State Key Laboratory of Molecular Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Thoracic Surgery II, Peking University Cancer Hospital and Institute…
- Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical Engineering, Beihang University, Beijing, 100191, China.
- School of Biomedical Engineering, Anhui Medical University, Hefei, 230032, China.
- Translational Medicine Center, Beijing Chest Hospital, Capital Medical University, Beijing Key Laboratory in Drug Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, 101…
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Tang, C., Dong, Z., Yan, S., Liu, B., Wang, Z., Cheng, L., Liu, F., Sun, H., Du, Y., Pan, L., Zhou, Y., Jin, Z., Zhao, L., Wu, N., Chang, L., & Xu, X. (2025). Microdroplet-enhanced chip platform for high-throughput immunotherapy marker screening from extracellular vesicle RNAs and membrane proteins. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2024.116748
Vancouver
Tang C, Dong Z, Yan S, Liu B, Wang Z, Cheng L, et al. Microdroplet-enhanced chip platform for high-throughput immunotherapy marker screening from extracellular vesicle RNAs and membrane proteins. Biosensors and Bioelectronics. 2025. doi:10.1016/j.bios.2024.116748
BibTeX
@article{Tang2025,
author = {Tang, Chuanhao and Dong, Zaizai and Yan, Shi and Liu, Bing and Wang, Zhiying and Cheng, Long and Liu, Feng and Sun, Hong and Du, Yimeng and Pan, Lu and Zhou, Yuhao and Jin, Zhiyuan and Zhao, Libo and Wu, Nan and Chang, Lingqian and Xu, Xiaojie},
title = {Microdroplet-enhanced chip platform for high-throughput immunotherapy marker screening from extracellular vesicle RNAs and membrane proteins},
journal = {Biosensors and Bioelectronics},
year = {2025},
doi = {10.1016/j.bios.2024.116748}
}
EUVIMED